Latent inhibition and its potential as a biomarker for schizophrenia
The biological heterogeneity of schizophrenia continues to be a major obstacle for clinical practice and the development of novel drug treatments. A non-invasive biomarker to define sub-groups of patients with common neurobiological underpinnings would dramatically improve detection, diagnosis and t...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-12-01
|
| Series: | Biomarkers in Neuropsychiatry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666144620300150 |